A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrated a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
Promising pathway for predictive biomarkers in lung cancer immunotherapy revealed
- Post author:
- Post published:September 9, 2024
- Post category:uncategorized
- Post comments:0 Comments